{"name":"ADC Therapeutics S.A.","slug":"adc-therapeutics-s-a","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":81357000,"revenueGrowth":14.9,"grossMargin":0,"rdSpend":104005000,"netIncome":-142623000,"cash":323150000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"ADCT-901","genericName":"ADCT-901","slug":"adct-901","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"ADCT-901","genericName":"ADCT-901","slug":"adct-901","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxOT2kyejZveWFQLXAydUVZUlRtTlAyZW1NUHVneTZvNzF0X0w2cGt6WGlqOW9qRmp4c1RuNm1UZXVCUXctUk54SlFaT2RRdzZuTUFJVkRhRzNJVmVFOTJ2cEZBazU5ZUJvWElfNnhxWDVUc1VVSWxDRVdwNjRPTGRXTjFfVVdDa0FyU01SNklHR0xlX0hCcVBRdGZDcw?oc=5","date":"2026-04-08","type":"pipeline","source":"openPR.com","summary":"Key Strategic Factors and Emerging Trends Shaping the Acute - openPR.com","headline":"Key Strategic Factors and Emerging Trends Shaping the Acute","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOMlNDbGZ3cW5kWGU2eUozS0FUQVlOZzFKbkR4NUxSd25Oc2kzSGdCQmZHMnlsSlRyUVVtTHY1dUE4SkltSG9obmRNajhxSXhLUmpJeVdyYmM4MklVT1BpbTJiNFM5b2F2cXVVV2Q0UHpaNDJjU0tEYjNvTTRHMG1KZTdLeU9VZk1kWDRIY2pkWTBVMTQ?oc=5","date":"2026-03-30","type":"pipeline","source":"qz.com","summary":"Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year? - qz.com","headline":"Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQOVBsclllQXloM0t5cDRRUDBFVE1PWE1aVGJ6WWJtVjY2bXcyTkcwR0hsNEZCMGo0NHl2T1MydEFjbml0U2tyZW8yMmFEY2pfaVBTenZoQTFWa3NQSlRvUVQ0QWhYZjJWQ0pEbzFhVmtCc091YlBvdWRTWWpCMnhaelJRSy15b3E2eHV0b3RETmp4elQtczVHV19IVXhtVUM3M1R5NmZxa25PSWph?oc=5","date":"2026-03-30","type":"pipeline","source":"Yahoo Finance","summary":"Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance","headline":"Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year?","sentiment":"neutral"},{"date":"2026-03-10","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-10","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-23","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxPRVRwX1ZBeFJ4QVRtWTZmWWFBbmhTNmNiLWlTdUVuS3JTekhJQ0cxOFN0N2NpOGNVQVZSd3VKdDhzNFhNeEN2b0lqSzBmME1vLUdXdlpyT05YN2xzVmZLc2t2YWF5ZVlmYlgwNXdhaE9FZUVNZm5vYXpmWUt4TWJPZFhISHk4QkpJM0xFTWV4SldqZ05FYl9zelVjT0tWbFdISEIzbFFwNGM1UFJNekQ1czZiQng5M2I1QlRpZk8wLW5PYmphQXRMT3dNZGszYmZCazZuS2JpM3U3MkdGLUI5VzJR0gHnAUFVX3lxTE53Nmd6OGVkSC1SVzJ3MmNrV0JEb1FxT3dGSWd4UDAzMTdrNXZhQ1ZmSkdadVNuZmNreWVtRUMweEpGS2N3UlBIRU91MTNMQ0ZDaEMtQTRwLUt1Q2ttVDk3cU01V0ppajM4eXFmNmIyT2xKUVhNX24zNEZnb0RhY2pXQmdDTF9SUHJZQXBGMzBTbGdRSXVMMmlFTkpsSi15MlFXRTJ1ZEdPUEpwZ01hWkxCZ0hfNHdQV3A0NkZSNDhTeWdDNkZvT0JTaHZ3VVlCc0otcm5GRThUalBNT1ZBcEItTUtrVmxSdw?oc=5","date":"2026-02-05","type":"pipeline","source":"simplywall.st","summary":"ADC Therapeutics SA's (NYSE:ADCT) Price Is Right But Growth Is Lacking - simplywall.st","headline":"ADC Therapeutics SA's (NYSE:ADCT) Price Is Right But Growth Is Lacking","sentiment":"neutral"},{"date":"2026-01-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: FORM 8-K","headline":"SEC 8-K: FORM 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxORC0yVWlnQnEyR1FoMFRTRFl0emNDZUJJWTd5cUsxazU5QW5DYVJNRnNTclY3RzFvczVHLUI5Tm5wS0RtS1RRSE85ekNwaHQtWk5va05INzZGWlRLWEZWUWxDYVhUNTllcTA0bWF1ZGxQYnFYbjV0QklRYzAxNURHR2UyN0txYWxoMEhIQzNjZjVjR1RDSWdEeGdQS2E4UGhvaG1iQ3ZIRXBRRF9qVXpPVE5n?oc=5","date":"2026-01-02","type":"pipeline","source":"PR Newswire","summary":"ADC Therapeutics Announces New Employee Inducement Grant - PR Newswire","headline":"ADC Therapeutics Announces New Employee Inducement Grant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxQTm9qRFRSdjNtTWdKS0gwMkIwT2R4eGF3OFBnN0tDMHg4MFBYc0tYV0hOYUluUVhieWRLdTktNTNYZjRaQVJ6eEtBV3hYeERtMnV0ZUZZelNDdHZxQk83b08takttQjlDREVFWnVFODJlWTVPU2lCMzFjS1Yxc2FwZTJCZzVVWVFZLXV4NXRJMjNvY2RSMmhvQXdFM0tCVFVEQVRtV1AzT0NlT0pVWktiZkUyV2VaVWFzcE1ZcXlTd1d4QkZEZWFBazgzM1JIVWEwaWlmQ3JqREloZ0puYm5HVUR4SkQ3RTZkTUdSLWJCeWJJd0YzenpUcVZGNGc5c0QtdWhqaDQ2clFrakU?oc=5","date":"2025-12-19","type":"pipeline","source":"Finansavisen","summary":"Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines - Finansavisen","headline":"Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxPaDNjcWtpeDAzbkRMbkVhS01ZbENJelI1YjktTWZnMWljT0d2dm1wUDY1SG13d2R1emJ5MXRzOFRDbVJPZURJelhQN0tCR3ZWNExMSWxxVnhhZ29YNklYeGFKV1prUnFCMGtYR2ItTmtLNTI1djBLaDd5VHZZLXRrS3ZDSmpKZUs3VUl3?oc=5","date":"2025-12-17","type":"pipeline","source":"Yahoo Finance","summary":"Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance","headline":"Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOU2FnUmdSYWk3YjFhT0w3YlBhQU90V3pfaFBpUlBNWllpamZRdldjZk9Uck1ONnRFVDJ6aFk3UVlRaHg3SXdUMDc2YS1fUHA1NHdLQUdmTUdQNXkyTmZ5Z054TmtrTTFwal9TclRqZ19DRktGZnhWUnZDdTJZZGxnNngxbXpYLXdCSFpORlZjNFY?oc=5","date":"2025-12-01","type":"pipeline","source":"Yahoo Finance","summary":"Is ADC Therapeutics (ADCT) Outperforming Other Medical Stocks This Year? - Yahoo Finance","headline":"Is ADC Therapeutics (ADCT) Outperforming Other Medical Stocks This Year?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-11-07","type":"pipeline","source":"simplywall.st","summary":"Hedge funds investors in ADC Therapeutics SA (NYSE:ADCT) see US$53m decrease in market cap last week, although long-term gains have benefitted them. - simplywall.st","headline":"Hedge funds investors in ADC Therapeutics SA (NYSE:ADCT) see US$53m decrease in market cap last week, although long-term","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxOMzdBMXNDbkdOZWpaZDNSbHVMdFJtcWFLbHkxTnRQWGhKdmRlTlkya3pIaDR5Xzd6UUpSZHNqY2xvMGwxeGU3QXUwdVBFN1R4bU52OVE3R0E4TjdJaWlJUzFaMGN6a0JsY3ZreWZSNmJBX0xEWDFLVy1Hb2lyc2xwRDhMYXA3VmRQam1LYkc5NkJkZ1poWTVPWkZrcTNuU3l3NGRZeGRqakl6TnpTbVpBOGtSdFpVNzMtSWpBS3dkWlJoekdHUW1VX1hMOWNrckdEdFF5c3lPQVY5b2JEWTBJcFJqZEE?oc=5","date":"2025-08-12","type":"earnings","source":"PR Newswire","summary":"ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update - PR Newswire","headline":"ADC Therapeutics Reports Second Quarter 2025 Financial Results and Provides Operational Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE82anhJb1d5NHJiOXBQQ1V3T25YWjlGMGxQNHFsWDlmbWI0eDYwY2YtaVNQcWgzaW1tbHUxYnRySHN5YWNPSHBwQ3I2M2YyTE9GS2cw?oc=5","date":"2025-06-12","type":"pipeline","source":"FirstWord Pharma","summary":"ADC Therapeutics axes 30% of staff, closes UK facility - FirstWord Pharma","headline":"ADC Therapeutics axes 30% of staff, closes UK facility","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":81357000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":81357000,"period":"2025-12-31"},{"value":70837000,"period":"2024-12-31"},{"value":70837000,"period":"2024-12-31"},{"value":69558000,"period":"2023-12-31"},{"value":69558000,"period":"2023-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":104005000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-142623000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":323150000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}